Pfizer Inc (PFIZ34) — Cash Flow-to-Debt Ratio
Pfizer Inc (PFIZ34) has a Cash Flow-to-Debt Ratio of 0.02x as of March 2026, meaning its operating cash flow of R$2.62 Billion could theoretically repay 0% of its total liabilities (R$117.21 Billion) in one year. Explore how much of Pfizer Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pfizer Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Pfizer Inc across 12 annual periods. Also explore PFIZ34 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Pfizer Inc (2014–2025)
Year-by-year debt coverage analysis for Pfizer Inc. For market capitalisation and broader financial context, see Pfizer Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (BRL) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | R$11.71 Billion | R$121.39 Billion | ▼ -5.5% |
| 2024 | 0.10x | R$12.74 Billion | R$124.90 Billion | ▲ +16.3% |
| 2023 | 0.09x | R$12.04 Billion | R$137.21 Billion | ▼ -69.6% |
| 2022 | 0.29x | R$29.27 Billion | R$101.55 Billion | ▼ -7.8% |
| 2021 | 0.31x | R$32.58 Billion | R$104.28 Billion | ▲ +97.4% |
| 2020 | 0.16x | R$14.40 Billion | R$90.99 Billion | ▲ +31.4% |
| 2019 | 0.12x | R$12.59 Billion | R$104.45 Billion | ▼ -26.9% |
| 2018 | 0.16x | R$15.83 Billion | R$96.02 Billion | ▼ -1.4% |
| 2017 | 0.17x | R$16.80 Billion | R$100.49 Billion | ▲ +15.7% |
| 2016 | 0.14x | R$16.19 Billion | R$112.07 Billion | ▲ +0.7% |
| 2015 | 0.14x | R$14.69 Billion | R$102.38 Billion | ▼ -19.4% |
| 2014 | 0.18x | R$17.08 Billion | R$95.94 Billion | — |